Medicines Co shares shot up on Monday after it was reported that Novartis will be acquiring the firm. The transaction was unanimously approved by the boards of directors of both companies.
Chris Lange Medicines shares shot up on Tuesday after it was reported that Novartis might be eyeing this company as its newest acquisition.
Chris Lange The top analyst upgrades, downgrades and initiations seen on Wednesday included DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq, Novartis, PayPal, Snap and Vishay.
Tilray shares made a solid gain on Tuesday after the company announced that it entered a global agreement to collaborate with Sandoz, a subsidiary of Novartis.
Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see…
Endocyte shares were up sharply early Thursday after it was announced that the company would be acquired.
Chris Lange The founders of Instagram leave the company, Novartis to cut hundreds of jobs, crude oil prices jump above $80 a barrel, and other important business headlines.
The top analyst upgrades, downgrades and initiations seen on Tuesday include Baker Hughes, CBS, Generac, Halliburton, Nike, PG&E, Snap, Tesla, Weatherford and Western Digital.
2018 has been a strange time for investors. While the U.S. stock market sits close to all-time highs, many of the emerging and other developed markets nations have seen their shares take…
The topic of acceptable costs versus acceptable results is one that may never have a final conclusion in which everyone agrees.
Adamis Pharmaceuticals saw its shares shoot up early on Monday after the firm announced a partnership with a subsidiary of Novartis.
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the…
The top analyst upgrades, downgrades and other research calls from Tuesday include Agnico Eagle Mines, Ford, Marathon Petroleum, Roku, Spotify and Quest Diagnostics.
Amgen shares saw a nice bump after the FDA on Thursday approved its preventive treatment of migraine in adults.
These four top companies could be very attractive to large cap biotechs looking to add gene and cell therapy drugs to their portfolios.
